Download PDF
Thorac Cardiovasc Surg 2017; 65(06): 475-478
DOI: 10.1055/s-0037-1601313
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

An Extrapericardial Minimally Invasive Approach for Implantable Cardioverter Defibrillator

Jeko M. Madjarov
1   Department of Cardiothoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States
,
Michael G. Katz
2   Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
,
Brad Poole
1   Department of Cardiothoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States
,
Svetozar Madzharov
1   Department of Cardiothoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States
,
John M. Fedor
1   Department of Cardiothoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States
,
Francis Robicsek
1   Department of Cardiothoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States
› Author Affiliations
Further Information

Publication History

28 October 2016

20 February 2017

Publication Date:
21 March 2017 (online)

    Permissions and Reprints All articles of this category

Abstract

The indications for placement of an implantable cardioverter defibrillators (ICDs) have greatly expanded over the last years. However, standard transvenous approach is not suitable for a subset of patients who cannot benefit from ICD therapy. Here, we have demonstrated the feasibility and efficacy of extrapericardial ICD placement through a minimally invasive access in intact hearts as well as in postmyocardial infarction large animal models. Based on our data, we conclude that extrapericardial ICD placement is a feasible approach that may be a valuable alternative or adjunct to current defibrillator lead systems.

Keywords

implantable cardioverter defibrillator - extrapericardial approach - large animal model

Note

Presented at the 9th Annual Meeting on Arrhythmia and Cardiac Surgery, Brisbane, Australia, July 14–15, 2016.


 

  • References

  • 1 Berul CI, Van Hare GF, Kertesz NJ. , et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51 (17) 1685-1691
    CrossrefPubMedGoogle Scholar
  • 2 Blom NA. Implantable cardioverter-defibrillators in children. Pacing Clin Electrophysiol 2008; 31 (Suppl. 01) S32-S34
    CrossrefPubMedGoogle Scholar
  • 3 Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004; 27 (09) 1292-1305
    CrossrefPubMedGoogle Scholar
  • 4 Czapla J, Wellens F, Nijs J, La Meir M. Video-assisted thoracoscopic implantation of cardioverter-defibrillator systems. Ann Thorac Surg 2014; 98 (05) 1855-1857
    CrossrefPubMedGoogle Scholar
  • 5 Clark BC, Davis TD, El-Sayed Ahmed MM. , et al. Minimally invasive percutaneous pericardial ICD placement in an infant piglet model: head-to-head comparison with an open surgical thoracotomy approach. Heart Rhythm 2016; 13 (05) 1096-1104
    CrossrefPubMedGoogle Scholar
  • 6 Chevalier P, Moncada E, Canu G. , et al. Symptomatic pericardial disease associated with patch electrodes of the automatic implantable cardioverter defibrillator: an underestimated complication?. Pacing Clin Electrophysiol 1996; 19 (12 Pt 1): 2150-2152
    CrossrefPubMedGoogle Scholar
  • 7 Jarman JW, Lascelles K, Wong T, Markides V, Clague JR, Till J. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 2012; 33 (11) 1351-1359
    CrossrefPubMedGoogle Scholar